More particularly, the present invention involves administering an IL-17antagonist such as IL-17 receptor, to an individual inflicted with rheumatoid arthritis, for a period of time sufficient to induce a sustained improvement in the patient's condition.DETAILED DESCRIPTION OF THE INVENTIONThe present invention provides methods for treating an individual including a human, who is suffering from a